Dominic Smethurst - 06 Mar 2025 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Signature
/s/ Meghan Houghton, Attorney-in-Fact for Dominic Smethurst
Issuer symbol
CRBP
Transactions as of
06 Mar 2025
Net transactions value
-$43,330
Form type
4
Filing time
07 Mar 2025, 16:30:08 UTC
Previous filing
04 Feb 2025
Next filing
16 Jan 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock, par value $0.0001 per share Sale $43,330 -6,393 -8.3% $6.78 70,807 06 Mar 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This amount includes 64,700 unvested RSUs subject to each grant's vesting schedule as previously reported.